Delivery Order SPE2DR25D1022-SPE2DR26FQT0V
Award Date 12/29/25
Potential Completion Date 1/21/26
Potential Value $8.6K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $8,559.84 delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Ibrance 100 mg capsules (21-count). This competitive, non-set-aside contract represents a firm fixed price delivery order with an ultimate completion date of January 8, 2026, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award is a child contract issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a $17,122.82 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Ibrance 75 mg capsules (21-count packages), with delivery expected by December 23, 2025. This competitive award carries no set-aside designation and is being performed at the contractor's corporate headquarters in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Ibrance 125 mg capsules (21-count units) with a contract ceiling value of $8,555.21. This is a firm fixed-price delivery order with an ultimate completion date of January 2, 2026, representing a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was competitively made with no set-aside designation, and...
- The Defense Logistics Agency awarded a $8,555.21 delivery order to AmerisourceBergen Drug Corp for Ibrance 125 mg capsules (quantity 21) on December 20, 2025, with completion targeted for January 13, 2026. This is a firm fixed-price, non-competitive set-aside delivery order issued to the prime contractor's corporate office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as...
- The Defense Logistics Agency awarded a $8,555.21 delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Ibrance 125 mg capsules (21-count packages). This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of December 30, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $8,123.96 to AmerisourceBergen Drug Corp for the supply of Ibrance 75 mg capsules (21-count package) on August 1, 2025, with an ultimate completion date of August 22, 2025. The contract is structured as a firm fixed price delivery order with no set-aside designation, meaning it was competitively awarded. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this...
- The Defense Logistics Agency awarded a delivery order valued at $8,555.21 to AmerisourceBergen Drug Corp for the supply of Ibrance 125 mg capsules (21-count packages) on November 26, 2025, with an ultimate completion date of December 18, 2025. This firm fixed-price delivery order is unclassified as a set-aside and represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026....
- The Defense Logistics Agency awarded a delivery order valued at $8,118.08 to AmerisourceBergen Drug Corp for the supply of Ibrance 125 mg capsules (21-count) on August 19, 2025, with completion targeted for September 10, 2025. The contract utilizes firm fixed pricing and was competitively awarded without a set-aside designation. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office location....
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Ibrance 125 mg capsules (21-count packages) valued at $8,555.21 with a firm fixed price structure. The contract is classified as a non-set-aside, competitively awarded delivery order with an ultimate completion date of December 24, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location....
- The Defense Logistics Agency awarded a delivery order valued at $8,118.08 to AmerisourceBergen Drug Corp for the supply of Ibrance 125 mg capsules (21-count) on August 29, 2025, with completion expected by September 22, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award to the pharmaceutical distributor's corporate office in Conshohocken, Pennsylvania. The award is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...